Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27

Journal of Molecular Medicine

Volumn 82, Issue 10, 2004, Pages 688-695

  Diedrichs, H ^a,b,c,d   Mei, C ^b   Frank, K F ^b   Boelck, B ^b   Schwinger, R H G ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Lab of Muscle Res/Molec Cardiol   (Germany)

^d Internal Medicine   (Germany)

Author keywords

Calcineurin; GATA 4; Hypertrophy; Nuclear factor activated T cell 3; TGR(mREN2)27

Indexed keywords

BIOLOGICAL MARKER; CALCINEURIN; CALCINEURIN B; CALCIUM; CALMODULIN; DNA; PHOSPHATASE; RENIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT 3; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE OVEREXPRESSION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; RAT STRAIN; REN2 GENE; RISK FACTOR; TGR(MREN2)27 GENE; TRANSGENIC ANIMAL; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOTTING, WESTERN; CALCINEURIN; CARDIOMEGALY; DNA-BINDING PROTEINS; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; MALE; MICE; MYOCARDIUM; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RENIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 7944220273     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-004-0581-9     Document Type: Article

References (45)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322:1561-1566
2. Ho KK, Levy D, Kannel WB, Pinsky JL (1993) The epidemiology of the heart failure. The Framingham study. J Am Coll Cardiol 22:6-13
3. Dominguez LJ, Parrinello G, Amato P, Licata G (1999) Trend of congestive heart failure epidemiology: contrast with clinical trial results. Cardiology 44:801-8
4. Mably JD, Liew C (1996) Factors involved in cardiogenesis and the regulation of cardiac-specific gene expression. Circ Res 79:4-13
5. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP (1987) Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61:70-76
6. Beuckelmann DJ, Nabauer M, Erdmann E (1992) Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85:1046-1055
7. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228
8. Olson EN, Molkentin JD (1999) Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype? Circ Res 84:623-632
9. Barinaga M (1998) Signalling path may lead to better heart-failure therapies. Science 280 383
10. Shimoyama M, Hayashi D, Takimoto E, Zou Y Oka T, Komuro I (1999) Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation 100:2449-54
11. Luo Z, Shyu KG, Gulaberto A, Walsh K (1998) Calcineurin inhibitors and cardiac hypertrophy. Nat Med 10:1092-1093
12. Sugden PH (1999) Signalling in myocardial hypertrophy: life after calcineurin? Circ Res 84:633-646
13. Lim HW, Molkentin JD (1999) Calcineurin and human heart failure. Nat Med 5:246-247
14. Tsao L, Neville C, Musaro A (2000) Revisiting calcineurin and human heart failure. Nat Med 6:2-3
15. Haq S, Molkentin JD (2001) Differential activation of signal transduction pathway in human hearts with hypertrophy versus advanced heart failure. Circulation 103:670-677
16. Molkentin JD, Olson EN (1997) GATA4: a novel transcriptional regulator of cardiac hypertrophy? Circulation 96:3833-35
17. Xia Y, McMillin B, Lewis A, Moore M, Zhu WG, Williams RS, Kellems RE (2000) Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA-4 pathway and up-regulates the adenylosuccinate synthetase 1 gene. J Biol Chem 275:1855-1863
18. Herzig TC, Jobe SM, Aoki H (1997) Angiotensin II type Iα receptor gene expression in the heart: AP-1 and GATA-4 participate in the responses to pressure overload. Proc Natl Acad Sci USA 94:7543-48
19. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275:1930-33
20. Liang QG, De Windt LJ, Witt SA, Molkentin JD (2001) The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276:30245-30253
21. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Molkentin JD (1998) Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281:1690-93
22. Taigen T, De Windt LJ, Lim HW, Molkentin JD (2000) Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 97:1196-1201
23. Rothermel BA, McKinsey TA, Vega RB, Nicol RL, Williams RS (2001) Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 98:3328-3333
24. Rothermel BA, Vega RB, Williams RS (2003) The role of modulatory calcineurin-interacting proteins in calcineurin signalling. Trends Cardiovasc Med 13:15-21
25. Ding B Price RL, Borg TK, Weinberg EO Halloran PF, Lorell BH (1999) Pressure overload induces severe hypertrophy in mice treated with cyclosporin, an inhibitor of calcineurin. Circ Res 84:729-734
26. Zhang W Kowal RC Rusnak F, Sikkink RA, Olson EN, Victor RG (1999) Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res 84:722-728
27. Bachmann S, Peters J, Engler E, Ganten D, Mullins J (1992) Transgenic rats carrying the mouse renin gene-morphological characterization of a low-renin hypertension model. Kidney Int 41:24-36
28. Zhao Y, Bader M, Kreutz R, Fernandez-Alfonso M, Zimmermann F, Ganten U, Metzger R, Ganten D, Mullins JJ, Peters J (1993) Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27. Am J Physiol 265:699-707
29. Zobel C, Brixius K, Pietsch M, Munch G, Bolck B, Schwinger RH (1998) Unchanged sarcoplasmic reticulum Ca2+-ATPase activity, reduced Ca2+ sensitivity, and negative force-frequency relationship in transgenic rats overexpressing the mouse renin gene. J Mol Med 76:533-44
30. Zobel C, Brixius K, Frank K, Schwinger RH (1998) Effect of the Na+-channel modulator BDF 9148 on Ca2+-sensitivity and force of contraction of hypertrophic myocardium from transgene rats harboring the mouse Renin gene (TG (mREN2)27). Naunyn Schmiedebergs Arch Pharmacol 357:532-9
31. Munch G, Boelck B, Karczewski P, Schwinger RH (2002) Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium. J Mol Cell Cardiol 34:321-34
32. Schwinger RH, Böhm M, Schmidt U, Erdmann E (1995) Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca (2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92:3220-8
33. Deryckere F, Cannon F (1994) A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16:405
34. Diedrichs H, Chi M, Boelck B, Schwinger RHG (2004) Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure. Eur J Heart Fail 6:3-9
35. Schwarz B, Percy E, Gao XM, Dart AM, Richardt G, Du XJ (2003) Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload. Eur J Heart Fail 5:131-6
36. Hasegawa K, Lee SJ, Jobe SM et al (1997) Cis-acting sequences that mediate induction of β-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation 96:3943-53
37. Liang Q, Wiese RJ, Bueno OF, Dai Y-S, Markham BE, Molkentin JD (2001) The transcription factor GATA 4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 21:7460-7469
38. Fu M, Xu S, Zhang J, Pang Y, Liu N, Su J, Tang C (1999) Involvement of calcineurin in angiotensin II-induced cardiomyocytes hypertrophy and cardiac fibroblast hyperplasia of rats. Heart Vessels 14:283-288
39. Goldspink PH, McKinney RD, Kimball VA, Geenen DL, Buttrick PM (2001) Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporine A in adult rats. Mol Cell Biochem 226:83-88
40. Yang TTC, Xiong QF, Enslen H, Chow CW (2002) Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol Cell Biol 22:3892-3904
41. Mitchell KD, Jacinto SM, Mullins JJ (1997) Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol 273:246-53
42. Bohm M, Lee M, Kreutz R, Kim S, Schinke M, Djavidani B, Wagner J, Kaling M, Wienen W, Bader M et al (1995) Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions. J Hypertens 13:891-9
43. Langheinrich M, Lee MA, Bohm M, Pinto YM, Ganten D, Paul M (1996) The hypertensive Ren-2 transgenic rat TGR(mREN2)27 in hypertension research. Characteristics and functional aspects. Am J Hypertens 9:506-12
44. Takahashi N, Saito Y, Kuwahara K, Harada M, Kishimoto I, Ogawa Y, Kawakami R, Nakagawa Y, Nakanishi M, Nakao K (2003) Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation. Hypertens Res 26:847-53
45. De Borst MH, Navis G, de Boer RA, Huitema S, Vis LM, van Gilst WH, van Goor H (2003) Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats. Lab Invest 83:1761-70